Optimizing Air Flow in Pharmaceutical Manufacturing
Unidirectional vs. turbulent airflow strategies for OSD, sterile fill-finish, and biologics suites — engineered for EU GMP Annex 1 (2022) compliance.
EU GMP Annex 1 (revised 2022) reframed contamination control around a holistic Contamination Control Strategy (CCS), with airflow visualization and smoke studies elevated to mandatory qualification activities for Grade A zones.
Choosing the airflow regime
Unidirectional (laminar) airflow at 0.36–0.54 m/s ±20% remains the reference for Grade A critical zones — RABS interiors, isolator workspaces, and aseptic filling lines. Turbulent mixing flow is acceptable for Grade B background and Grade C/D support areas, provided the room-level air change rate sustains the required particulate class.
REGULATORY CITATION“EU GMP Annex 1 §4.29 — The Grade A zone shall be protected by a unidirectional airflow with a guidance velocity of 0.36–0.54 m/s at the working position.”
Engineering for the working position
The velocity specification is measured at the working position, not at the filter face. This single distinction drives terminal HEPA layout, room height, and equipment placement decisions. Misreading it produces suites that pass FAT and fail PQ.
- Smoke studies under dynamic conditions, not at-rest only
- First-air protection of all exposed product and components
- Recovery testing tied to defined CCS interventions
- Continuous viable + non-viable monitoring with trending